UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

The lancet oncology, 2012-05, Vol.13 (5), p.501-508

2012

Volltextzugriff (PDF)

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

Clinical cancer research, 2008-05, Vol.14 (10), p.3060-3069

2008

Volltextzugriff (PDF)

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

Cancer Immunology, Immunotherapy, 2010-05, Vol.59 (5), p.663-674

2010

Volltextzugriff (PDF)

A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

Clinical cancer research, 2011-11, Vol.17 (22), p.7164-7173

2011

Volltextzugriff (PDF)

Clinical Safety of a Viral Vector Based Prostate Cancer Vaccine Strategy

The Journal of urology, 2007-10, Vol.178 (4), p.1515-1520

2007

Volltextzugriff (PDF)

Vaccine Therapy of Established Tumors in the Absence of Autoimmunity

Clinical cancer research, 2003-05, Vol.9 (5), p.1837-1849

2003

Volltextzugriff (PDF)

Effect of Talactoferrin Alfa on the Immune System in Adults With Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2013-07, Vol.18 (7), p.821-822

2013

Volltextzugriff (PDF)

Nutritional status in the HEMO study cohort at baseline

American journal of kidney diseases, 2002-02, Vol.39 (2), p.245-256

2002

Volltextzugriff (PDF)

Modified vaccinia virus Ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7942-7949

2003

Volltextzugriff (PDF)

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

Cancer Immunology, Immunotherapy, 2010-01, Vol.59 (1), p.63-71

2010

Volltextzugriff (PDF)

General Keynote: Vaccine Strategies for the Therapy of Ovarian Cancer

Gynecologic oncology, 2003, Vol.88 (1), p.S97-S104

2003

Volltextzugriff (PDF)

Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen

Cancer research (Chicago, Ill.), 1988-08, Vol.48 (16), p.4588-4596

1988

Volltextzugriff (PDF)

Evaluation of the traumatic brain injury early referral programme in Missouri

Brain injury, 2007, Vol.21 (12), p.1295-1302

2007

Volltextzugriff (PDF)

Abstract 1260: Generation of human T cells directed against an agonist epitope of a transcription factor involved in epithelial to mesenchymal transition (EMT)

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1260-1260

2013

Volltextzugriff (PDF)

Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer

The Prostate, 2002-10, Vol.53 (2), p.109-117

2002

Volltextzugriff (PDF)

Abstract 2546: Analysis of immune cell subsets in a multidrug therapeutic regimen for patients with metastatic castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2546-2546

2014

Volltextzugriff (PDF)

The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: Results of the HEMO Study

Kidney international, 2004-06, Vol.65 (6), p.2321-2334

2004

Volltextzugriff (PDF)

Abstract 5524: Generation of cellular immune responses to MUC1-C to target the portion of MUC1 that is most biologically relevant to the transformation process

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5524-5524

2011

Volltextzugriff (PDF)

Abstract 5379: Combination treatment with Bevacizumab, Lenalidomide, Docetaxel and Prednisone (ART-P) does not impact the immune response in patients with metastatic castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5379-5379

2012

Volltextzugriff (PDF)

Serological mapping of the TAG-72 Tumor-associated antigen using 19 distinct monoclonal antibodies

Cancer research (Chicago, Ill.), 1990-08, Vol.50 (16), p.4872-4879

1990

Volltextzugriff (PDF)

Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results From the HEMO study

Journal of renal nutrition, 2003-07, Vol.13 (3), p.191-198

2003

Volltextzugriff (PDF)

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)

Journal for immunotherapy of cancer, 2013-11, Vol.1 (S1), p.P202-P202, Article P202

2013

Volltextzugriff (PDF)

Baculovirus recombinants expressing the human carcinoembryonic antigen gene

Cancer research (Chicago, Ill.), 1993-05, Vol.53 (9), p.2154-2161

1993

Volltextzugriff (PDF)

The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines

Cancer Immunology, Immunotherapy, 2000-12, Vol.49 (10), p.517-529

2000

Volltextzugriff (PDF)

A Pilot Study to Evaluate the Safety and Clinical Outcomes of Vaccination with Recombinant CEA-MUC-1-TRICOM (PANVAC) Poxviral-based Vaccines in Patients with Metastatic Carcinoma

Clinical cancer research, 2008-05, Vol.14 (10), p.3060-3069

2008

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(108)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

Clinical Safety of a Viral Vector Based Prostate Cancer Vaccine Strategy

Vaccine Therapy of Established Tumors in the Absence of Autoimmunity

Effect of Talactoferrin Alfa on the Immune System in Adults With Non‐Small Cell Lung Cancer

Nutritional status in the HEMO study cohort at baseline

Modified vaccinia virus Ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

General Keynote: Vaccine Strategies for the Therapy of Ovarian Cancer

Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen

Evaluation of the traumatic brain injury early referral programme in Missouri

Abstract 1260: Generation of human T cells directed against an agonist epitope of a transcription factor involved in epithelial to mesenchymal transition (EMT)

Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer

Abstract 2546: Analysis of immune cell subsets in a multidrug therapeutic regimen for patients with metastatic castration-resistant prostate cancer

The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: Results of the HEMO Study

Abstract 5524: Generation of cellular immune responses to MUC1-C to target the portion of MUC1 that is most biologically relevant to the transformation process

Abstract 5379: Combination treatment with Bevacizumab, Lenalidomide, Docetaxel and Prednisone (ART-P) does not impact the immune response in patients with metastatic castration-resistant prostate cancer

Serological mapping of the TAG-72 Tumor-associated antigen using 19 distinct monoclonal antibodies

Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results From the HEMO study

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)

Baculovirus recombinants expressing the human carcinoembryonic antigen gene

The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines

A Pilot Study to Evaluate the Safety and Clinical Outcomes of Vaccination with Recombinant CEA-MUC-1-TRICOM (PANVAC) Poxviral-based Vaccines in Patients with Metastatic Carcinoma

Suchergebnisse filtern